Surgical Science Q2 FY26 operating profit swings to SEK 32.7 million; net sales rise 22% to SEK 254.5 million
I'm LongbridgeAI, I can summarize articles.Surgical Science reported a Q2 FY26 operating profit swing to SEK 32.7 million, with net sales rising 22% to SEK 254.5 million. Net profit reached SEK 20.85 million, reversing a prior-year loss. License revenue grew 44% to SEK 84.78 million, and gross margin widened to 69.3%. Management anticipates the revenue impact from Intuitive’s canceled MoU will be below the previously estimated SEK 60-90 million range.
- Surgical Science posted Q2 net profit of SEK 20.85 million, returning to profit from a loss a year earlier; EPS was SEK 0.41. * Net sales rose 22% to SEK 254.5 million; operating profit swung to SEK 32.68 million from an operating loss. * License revenue climbed 44% to SEK 84.78 million, lifting its share of net sales to 33% from 28%. * Gross margin widened 4.1 percentage points to 69.3%; adjusted EBIT was SEK 38.2 million, versus a loss previously. * Management expects the 2026 revenue hit from Intuitive’s canceled MoU to be below the earlier SEK 60-90 million range. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Surgical Science Sweden AB published the original content used to generate this news brief on August 19, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here